NeuroOne Medical Technologies Corporation Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for NMTC, updated each market day.
NMTC AI Sentiment
AI sees no strong directional signal for NeuroOne Medical Technologies Corporation Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About NeuroOne Medical Technologies Corporation Common Stock
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
Sector
Exchange
Market Cap
$37,386,100
Cap Tier
Employees
18
Headquarters
EDEN PRAIRIE, MN
Listed Since
Nov. 9, 2012
Website
NMTC Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
NMTC Volatility
NeuroOne Medical Technologies Corporation Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
